Hip abductor training for women with stress urinary incontinence
Effectiveness of a Hip Abductor Training in Women With Stress Urinary Incontinence
This program will test whether adding hip abductor exercises helps women with stress urinary incontinence improve leakage and quality of life compared with standard pelvic floor muscle training.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 78 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University Hospital, Rouen Academic / other |
| Locations | 3 sites (Caen and 2 other locations) |
| Trial ID | NCT05635175 on ClinicalTrials.gov |
What this trial studies
Adult women with stress urinary incontinence who are referred for perineal rehabilitation will be assigned to receive either hip abductor physiotherapy self-training, standard pelvic floor muscle training, or a self-training version of pelvic floor exercises. Treatments are delivered through physiotherapist-supervised programs or guided self-training and outcomes include urinary leakage frequency, pelvic floor function, and quality of life. Researchers will use clinical assessments and patient-reported questionnaires to compare symptom changes between groups over the treatment period. The design builds on imaging data suggesting gluteal and pelvic floor muscles activate overlapping brain regions and on prior physiotherapy work showing benefits of hip abductor training for lumbo-pelvic control.
Who should consider this trial
Good fit: Women aged 18 and older with stress urinary incontinence who have a prescription for perineal rehabilitation, can perform standing hip abductor exercises, and are covered by French health insurance.
Not a fit: Women with bladder tumors or interstitial cystitis, significant neurological diseases, pregnancy or breastfeeding, or who cannot safely perform hip abductor exercises are unlikely to benefit from this program.
Why it matters
Potential benefit: If successful, adding hip abductor exercises could increase continence rates and improve pelvic control and quality of life for women who do not fully respond to pelvic floor training.
How similar studies have performed: Prior imaging and physiotherapy studies show gluteal activation can support pelvic floor control and hip abductor training improves lumbo‑pelvic function, but using hip abductor training specifically to treat stress urinary incontinence is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women ≥ 18 ans * patient with urinary incontinence according to the ICS criteria \[3\] * having received a prescription for perineal rehabilitation * affiliated to french health care insurance * Patient having read and understood the information letter and signed the consent form * Effective contraception in women of childbearing age (negative urine pregnancy test). For postmenopausal women, a confirmatory diagnosis must be obtained (amenorrhea for at least 12 months before the inclusion visit) Exclusion Criteria: * Bladder pathologies (cyst, tumour, interstitial cystitis) * Neurological pathologies (multiple sclerosis, Parkinson's desease, etc.) * Pregnant or parturient or breastfeeding woman or absence of proven contraception * Person deprived of liberty by administrative or judicial decision or a person placed under the safeguard of justice, or guardianship or curatorship * Physical inability to perform hip abductors exercises (unable to walk or stand independently) * Women having scheduled continence surgery before the end of physiotherapy sessions at the time of randomization * Women having at least one of the continence-specific anticholinergic treatments prescribed before the end of the physiotherapy sessions at the time of randomization
Where this trial is running
Caen and 2 other locations
- Pôle santé de la Grace Dieu — Caen, France (Recruiting)
- Chu Rouen — Rouen, France (Recruiting)
- Médipôle du Rouvray — Saint-Étienne-du-Rouvray, France (Recruiting)
Study contacts
- Study coordinator: Benoit STEENSTRUP, physiotherapist
- Email: benoit.stennstrup@chu-rouen.fr
- Phone: +33 2 32 88 89 90
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.